Creating a new treatment for syphilis
Development of a Treatment for Syphilis
This study is looking for a new way to treat syphilis for people who might not get better with the usual medicines, aiming to help them feel better and improve their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nanohmics, INC. NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-11307371 on NIH RePORTER |
What this research studies
This research focuses on developing an alternative treatment for syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. The approach aims to create a therapeutic agent that could provide effective treatment options for patients who may not respond to existing therapies. By exploring innovative methods in therapeutic development, the research seeks to improve patient outcomes and address the challenges associated with current treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with syphilis who may benefit from alternative treatment options.
Not a fit: Patients who have already been effectively treated for syphilis with existing therapies may not receive additional benefits from this research.
Why it matters
Potential benefit: If successful, this research could provide a new and effective treatment option for patients with syphilis.
How similar studies have performed: While there have been various approaches to treating syphilis, the development of alternative treatments is an area that continues to seek innovative solutions, indicating a mix of both novel and tested methodologies.
Where this research is happening
Austin, United States
- Nanohmics, INC. — Austin, United States (Active)
Researchers
- Principal investigator: Savoy, Steve Michael — Nanohmics, INC.
- Study coordinator: Savoy, Steve Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.